Cytotoxic agents for the treatment of cancer
AssigneeCytRx Corporation
InventorDaniel Levitt
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of treating brain cancer comprising administering a therapeutically effective substance to a patient, wherein the therapeutically effective substance comprises: (I), or a pharmaceutically acceptable salt thereof, wherein X is a moiety that can be cleaved hydrolytically or enzymatically in the body of the patient in a pH-dependent manner.
Claims9
A pharmaceutical composition comprising a therapeutically effective substance for use in the treatment of brain cancer, wherein the therapeutically effective substance comprises DOXO-EMCH or a pharmaceutically acceptable salt thereof, wherein the therapeutically effective substance binds to serum albumin, and wherein the composition further comprises sodium bicarbonate and tert-butyl alcohol.
Dependencies are inferred from the claim text.